Sandbox sowminya: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:


{{Familytree/start}}
{{Familytree/start}}
{{Familytree|boxstyle=border: 0;| | | | | | A01 | | | | | | | | | | |A01={{F1|Age ≥ 55 or ⊕ alarm features?}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | A01 | | | | | | | | | | |A01={{F1|B-cell neoplasm; large cells}}}}
{{Familytree|boxstyle=border: 0;| |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| B01 | | | | | | | | B02 | | | | | |B01={{F1|YES}}|B02={{F1|NO}}}}
{{Familytree|boxstyle=border: 0;| | | | | B01 | | | | | | | | B02 | | | | | |B01={{F1|CD5+}}|B02={{F1|CD5-}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | |,|-|-|^|-|-|.| | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| C01 | | | | | | | | C02 | | | | | |C01={{F2|Endoscopy}}|C02={{F1|''H. pylori'' prevalence?}}}}
{{Familytree|boxstyle=border: 0;| | C01 | | | | C02 | | | | | C03 | | | | | |C01={{F1|CCND1+}}|C02={{F1|CCND1-}}|C03={{F2|DLBCL}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | |,|-|-|-|-|^|-|-|-|-|.| |}}
{{Familytree|boxstyle=border: 0;| | |!| | | | | |!| | | |,|-|-|^|-|-|.| | | |}}
{{Familytree|boxstyle=border: 0;| |!| | | | D01 | | | | | | | | D02 |D01={{F1|High}}|D02={{F1|Low}}}}
{{Familytree|boxstyle=border: 0;| | D01 | | | | D02 | | D03 | | | | D04 | | |D01={{F2|Pleomorphic MCL}}|D02={{F2|DLBCL, NOS CD5+}}|D03={{F1|CD10+}}|D04={{F1|CD10-}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | |!| | | | | | | | | |!| |}}
 
{{Familytree|boxstyle=border: 0;| |!| | | | E01 | | | | | | | | E02 |E01={{F2|Test-and-treat strategy ± acid suppression}}|E02={{F2|Acid suppression trial}}}}
 
{{Familytree|boxstyle=border: 0;| |`|-|-|-|-|+|-|-|-|-|-|-|-|-|-|'| |}}
 
{{Familytree|boxstyle=border: 0;| | | | | | F01 | | | | | | | | | | |F01={{F1|If eradication therapy is indicated}}}}
 
{{Familytree|boxstyle=border: 0;| |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
 
{{Familytree|boxstyle=border: 0;| G01 | | | | | | | | G02 | | | | | |G01={{F1|Clarithromycin resistance ≥ 20%}}|G02={{F1|Clarithromycin resistance < 20%}}}}
 
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| H01 | | | | | | | | H02 | | | | | |H01={{F2|Quadruple or sequential therapy}}|H02={{F2|PCA or PCM or Bismuth quadruple therapy}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| I01 | | | | | | | | I02 | | | | | |I01={{F2|PLA}}|I02={{F2|Bismuth quadruple therapy or PLA}}}}
{{Familytree|boxstyle=border: 0;| |`|-|-|-|-|v|-|-|-|-|'| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | J01 | | | | | | | | | | |J01={{F1|Adjust Rx per susceptibility test}}}}
{{Familytree|boxstyle=border: 0;| | | | | | |!| | | | | | | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | K01 | | | | | | | | | | |K01={{F2|Consider endoscopy if treatment fails}}}}
{{Familytree/end}}
{{Familytree/end}}
</div>

Revision as of 23:27, 21 August 2015





 
 
 
 
 
 
 
 
 
B-cell neoplasm; large cells
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD5+
 
 
 
 
 
 
 
CD5-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCND1+
 
 
 
CCND1-
 
 
 
 
DLBCL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pleomorphic MCL
 
 
 
DLBCL, NOS CD5+
 
CD10+
 
 
 
CD10-